34.99MMarket Cap
LossP/E TTM
GRCE Cash Flow Statement
You can access the annual and quarterly cash flow statements of Grace Therapeutics, Inc to evaluate its financial soundness and stability.
FAQs
What is operating cash flow?
Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.
How Much Operating Cash Flow Did Grace Therapeutics, Inc Generate?
Grace Therapeutics, Inc generated -8.87M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.
How Did Grace Therapeutics, Inc's Operating Cash Flow Change Year Over Year?
Grace Therapeutics, Inc's operating cash flow increased by 40.49% year over year.
What is investing cash flow?
Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.
What is financing cash flow?
Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.
How Has Grace Therapeutics, Inc's Financing Cash Flow Changed?
Grace Therapeutics, Inc used 3.71M in financing activities in the latest quarter.
What is free cash flow and why does it matter for GRCE?
Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
What was Grace Therapeutics, Inc’s free cash flow in the latest quarter?
Free cash flow was -8.87M reflecting a 40.49% change from the previous year.